SCHEMBL20049915

SCHEMBL20049915

CCCCC(C)(C)CCC(=O)N1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
LMNA P02545 2/20 0.49
RAB9A P51151 2/20 0.49
GLA P06280 1/20 0.49
TSHR P16473 1/20 0.49
HPGD P15428 1/20 0.48
ALDH1A1 P00352 1/20 0.48
PKM P14618 1/20 0.47
HTT P42858 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
GNAI3 P08754 1/20 0.42
GNAO1 P09471 1/20 0.42
GNAI1 P63096 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20112946 0.88 RAB9A (0.56) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL18922367 0.86 POLB (0.49) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL253804 0.81 GLA (0.64) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL179553 0.80 POLB (0.53) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL7101454 0.80 L3MBTL1 (0.66) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL2718359 0.80 L3MBTL1 (0.69) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL22199660 0.79 POLB (0.49) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL19618148 0.79 POLB (0.53) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL8971899 0.78 L3MBTL1 (0.67) POLBL3MBTL1LMNARAB9AGLA
SCHEMBL8972353 0.78 L3MBTL1 (0.67) POLBL3MBTL1LMNARAB9AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098983-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE, INC. 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098983-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS PIK3CA, AKT3, PIK3C2A POLB 2458/4885L3MBTL1 2802/4885LMNA 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.